Monday, June 4, 2012
Dividend Income Analysis: Eli Lilly (LLY)
Eli Lilly & Co. (LLY) discovers, develops, manufactures, and sells pharmaceutical products worldwide. LLY is the 10th largest pharmaceutical company in the world and operates in the healthcare sector. LLY used to be a strong dividend grower, but that growth has dried up since it made a large all-cash purchase of the biotechnology company ImClone. LLY is the first company I put through my dividend income analysis.